Home > Insider Trading > Filing (0001562180-22-007292)

Filing Details

Accession Number:: 0001562180-22-007292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-19 20:59:34
Reporting Period:: 2022-10-17

Accepted Time:: 2022-10-19 20:59:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404123	1Life Healthcare Inc	ONEM	Services-Offices & Clinics Of Doctors Of Medicine (8011)	760707204

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1800511	A Lisa Mango	C/O 1Life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco CA 94111	General Counsel And Secretary	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-10-17	2,472	$12.16	90,857	No	4	M	Direct
Common Stock	Disposition	2022-10-17	2,472	$17.06	88,385	No	4	S	Direct
Common Stock	Acquisiton	2022-10-19	2,500	$11.47	90,885	No	4	M	Direct
Common Stock	Disposition	2022-10-19	2,500	$17.06	88,385	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to buy)	Disposition	2022-10-17	2,472	$0.00	2,472	$12.16
Common Stock	Stock Option (Right to Buy)	Disposition	2022-10-19	2,500	$0.00	2,500	$11.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
96,420		2032-01-14	No	4	M	Direct
57,500		2029-09-18	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
This transaction was executed in multiple trades at prices ranging from $17.045 to $17.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $17.05 to $17.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 98,892 options instead of the reported 91,293. This number has been adjusted for the current filing to reflect the number of options beneficially owned.
The shares subject to the option vest as follows: 20% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/60th of the shares subject to the option vest monthly thereafter over the following four years, subject to reporting person's continuous service as of each such date.
On October 6, 2022, the reporting person filed a Form 4 in which the number of derivative securities beneficially owned following the reported transaction should have been 60,000 options instead of the reported 42,564. This number has been adjusted for the current filing to reflect the number of options beneficially owned.